AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 96 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $388,705 | +104.6% | 42,435 | +80.6% | 0.01% | -8.3% |
| Q4 2021 | $190,000 | +187.9% | 23,500 | +116.8% | 0.01% | +140.0% |
| Q2 2018 | $66,000 | -80.1% | 10,839 | -76.1% | 0.01% | -78.3% |
| Q1 2018 | $331,000 | +180.5% | 45,406 | +215.8% | 0.02% | +76.9% |
| Q4 2017 | $118,000 | -68.9% | 14,376 | -60.3% | 0.01% | -86.5% |
| Q3 2017 | $380,000 | +13.1% | 36,218 | +18.7% | 0.10% | +4.3% |
| Q2 2017 | $336,000 | +48.7% | 30,500 | +30.7% | 0.09% | +217.2% |
| Q1 2017 | $226,000 | – | 23,331 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 3,102,673 | $4,468,000 | 0.92% |
| JW Asset Management, LLC | 444,439 | $640,000 | 0.33% |
| BRANDES INVESTMENT PARTNERS, LP | 7,052,720 | $10,157,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,722,241 | $3,920,000 | 0.15% |
| Tekla Capital Management LLC | 814,588 | $1,173,000 | 0.05% |
| INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV | 34,750 | $50,000 | 0.04% |
| Brown Capital Management | 1,400,007 | $2,016,000 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 843,975 | $1,217,000 | 0.01% |
| WEDBUSH SECURITIES INC | 35,535 | $51,000 | 0.01% |
| Close Asset Management Ltd | 15,000 | $22,000 | 0.00% |